Do you have a product portfolio or business to sell or divest?

We have a strategic goal to increase the number and value of our own assets. Specifically, we are looking to acquire specialty pharma and OTC product portfolios and companies that would fit our core categories like, obesity, neurology, cardiology, gastroenterology, medical nutrition, urology/sexual health, cough & cold and pain management.

In 2022, Navamedic acquired the Swedish company Impolin AB, adding competent staff and the products Modifast^®, MedMade^®, Absolut Torr^™ to our portfolio.

In 2023, Navamedic acquired the Swedish listed company Sensidose AB, adding competent staff and the proprietary product Flexilev^® to our portfolio.